Autonomy Bio is an early-stage biotech company dedicated to pioneering drug development aimed at reducing multi-morbidity and establishing aging as a therapeutic area. They focus on creating innovative therapies that address the underlying causes of aging, rather than treating specific diseases. Their mission is to empower individuals with the autonomy to maintain their health and spend more quality time with their loved ones. By championing new regulatory pathways and fixed-dose combination drugs, Autonomy Bio works to redefine healthspan and longevity in a way that promotes healthier aging for everyone.